Beth Israel Medical Center, Site #145 — New York, New York

Beth Israel Medical Center, Site #145 is a clinical research site located in New York, New York, United States 10003.

Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.

Beth Israel Medical Center, Site #145 has participated in 1 clinical trials.

Therapeutic areas: Chronic Myeloid Leukemia.

Sponsors: Ariad Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Beth Israel Medical Center, Site #145?

Beth Israel Medical Center, Site #145 has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Beth Israel Medical Center, Site #145 conducted?

Beth Israel Medical Center, Site #145 has 1 clinical trials on record. Their work covers Chronic Myeloid Leukemia.

Is Beth Israel Medical Center, Site #145 accredited by Crixeo Health?

Beth Israel Medical Center, Site #145 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Beth Israel Medical Center, Site #145?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.